has been cited by the following article(s):
[1]
|
Letter: Middle Meningeal Artery Embolization Versus Conventional Treatment of Chronic Subdural Hematomas
Neurosurgery,
2022
DOI:10.1227/NEU.0000000000001858
|
|
|
[2]
|
Letter: Middle Meningeal Artery Embolization Versus Conventional Treatment of Chronic Subdural Hematomas
Neurosurgery,
2022
DOI:10.1227/NEU.0000000000001858
|
|
|
[3]
|
Letter: Middle Meningeal Artery Embolization Versus Conventional Treatment of Chronic Subdural Hematomas
Neurosurgery,
2022
DOI:10.1227/NEU.0000000000001858
|
|
|
[4]
|
Letter: Middle Meningeal Artery Embolization Versus Conventional Treatment of Chronic Subdural Hematomas
Neurosurgery,
2022
DOI:10.1227/NEU.0000000000001858
|
|
|
[5]
|
A Reliable Grading System for Prediction of Chronic Subdural Hematoma Recurrence Requiring Reoperation After Initial Burr-Hole Surgery
Neurosurgery,
2017
DOI:10.1093/neuros/nyx090
|
|
|
[6]
|
A Reliable Grading System for Prediction of Chronic Subdural Hematoma Recurrence Requiring Reoperation After Initial Burr-Hole Surgery
Neurosurgery,
2017
DOI:10.1093/neuros/nyx090
|
|
|
[7]
|
A Reliable Grading System for Prediction of Chronic Subdural Hematoma Recurrence Requiring Reoperation After Initial Burr-Hole Surgery
Neurosurgery,
2017
DOI:10.1093/neuros/nyx090
|
|
|